GWPH stock is one of the notable cannabis stock gainers in 2019. Let’s do a quick analysis of the recent developments from GW Pharmaceuticals (NASDAQ:GWPH).
Epidiolex Holds KeyAs everyone knows, the ultimate aim of many marijuana companies is to get into the pharmaceutical sector in a big way, and in that regard, only GW Pharmaceuticals has managed to be a success. The company has managed to become the first firm to produce an FDA-approved medicine produced from cannabis. The medicine in question is Epidiolex, and its launch has also propelled GWPH stock to new highs ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.